Prescribing Tips 2022 | Consortium of Lancashire & Cumbria LMCs

Index of Prescribing Tips 2022

PT 344 Yellow card

PT 345 Valproate packaging

PT 346 - Deprescribing High Strength Opioids

PT 347 - Inhaler ingredients - Avoiding Duplication Errors

PT 348 Co-prescribing Trimethoprim and Methotrexate. Emis Web protocol

PT 349 EMIS Web protocol - Clozapine

PT 350 Adding hospital only drugs onto EMIS web

PT 351 Proxy Access in Care Homes

PT 352 RAG colour classification of medication

PT 353 Use of steroid medication warning cards for children and young people

PT 354 Dapagliflozin -Forxiga- no longer authorised for Type 1 Diabetes

PT 355 Prescribing paracetamol for adult patients less than 50kg in weight

PT 356 COPD rescue therapy pathway update

PT 357 Emis Medication Screen Advice and Information

PT 358 LSCMMG Asthma Guidelines April 2022

PT 359 Reminder of risk of QT interval prolongation with Citalopram and Escitalopram

PT 360 Hydroxychloroquine warning prescribing tip

PT 361 Risks associated with co prescribing Lithium and NSAIDS

PT 362 Pregabalin in pregnancy

PT 363 Deprescribing Z-drugs

PT 364 Proxy ordering EMIS coding and documentation

PT 365 Propranolol toxicity in overdose

PT 366 Cancelling an Electronic Prescription

PT 367 Antimicrobial susceptibility report update

PT 368 Advice on metformin and reduced vitamin B12 levels

PT 369 Greener inhaler waste

PT 370 Haloperidol MHRA safety reminder

PT 371 Topiramate safety review

PT 372 C. Difficile Treatment Reminder Update NICE guideline

PT 373 Advice for prescribers - patients unable to swallow solid oral dosing forms

PT 374 LSC Greener inhaler resources

PT 375 Global shortage of ozempic and trulicity

PT 376 Antibiotic course length

PT 377 Documentation of medication allergies and adverse reactions

PT 378 Metolazone prescribing by brand name

PT 379 World Antimicrobial Awareness Week 2022

PT 380 Edoxaban CVD-06 IIF indicator

PT 381 Handihaler and Respimat advice

PT 382 Antibiotic supplies for patients with suspected GAS